Final stretch for clinical studies
Dr. Duane Mitchell’s research includes pioneering clinical trials in medulloblastoma (Re-MATCH) and gliomas (PEACH), which confirmed the potential of this approach as a platform for cure. In the following interview, Dr. Mitchell…
Guri trophy
The founder of MBI was honored in August 2023 with the 24th Guri Trophy, an important award created by Grupo RBS, from the state of Rio Grande do Sul….
II Workshop do Consórcio Cure Group 4
II Cure Group 4 Consortium Workshop: Clinical trials are coming! The most important highlight of the Consortium’s second in-person workshop is the announcement…
Global stage
On June 2, 2023, MBI founder Fernando Goldsztein spoke at a summit of entrepreneurs hosted by MIT, the MBA program where Fernando studied…
First in-person workshop for researchers
“We hope to have paved the way for treatment of this disease,” says Roger Packer of Children’s National Hospital in Washington DC (USA)…
Taking the lead against childhood brain cancer
In 2002, Fernando Goldsztein entered the MBA program at the Massachusetts Institute of Technology (MIT) to broaden his vision of management….
